EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of PD-L1 in breast invasive lobular carcinoma

Eunah Shin, Hye Min Kim, Ja Seung Koo iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0309170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Eunah Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: B7-H1 Antigen, Carcinoma, Lobular, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study was to investigate the expression of PD-L1 in invasive lobular carcinoma (ILC) and to determine its implications.

Methods

Tissue microarrays were constructed for 101 cases of ILC, and immunohistochemical staining for PD-L1 (using 22C3, SP142, and SP263 antibodies) was performed to examine the correlation between staining results and clinicopathologic parameters.

Results

The positive cut-off values were defined as tumor cell (TC)≥1%, immune cell (IC)>0%, and IC≥1%. The range of PD-L1 TC positivity was 0.0–2.0%, with PD-L1 SP263 TC showing the highest positivity of 2.0%. The range of PD-L1 IC positivity was 0–21.8% for IC ≥ 1%, with PD-L1 22C3 IC showing the highest positivity. When PD-L1 IC was positive (IC≥1%), the highest antibody agreement was observed between SP263 and SP142 (OA = 93.1%), while the lowest agreement was observed between 22C3 and SP263 (OA = 73.3%, κ = 0.040). PD-L1 22C3 IC positivity (≥1%) was associated with high nuclear grade (p = 0.002), HER-2 positivity (p = 0.019), and pleomorphic type (p = 0.002).

Conclusion

PD-L1 expression in ILC shows a low TC positivity rate (0–2%) with various antibody clones and a variable IC positivity rate (0–21.8%). Pleomorphic type ILC exhibits higher PD-L1 IC positivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenCarcinoma, LobularBreast NeoplasmsHumansFemaleMiddle AgedAgedAdultImmunohistochemistryBiomarkers, TumorAged, 80 and overTissue Array Analysis

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Ja Seung Koo

Zitieren

APA

Shin, E., Kim, H. M., & Koo, J. S. (2024). Expression of PD-L1 in breast invasive lobular carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0309170

Vancouver

Shin E, Kim HM, Koo JS. Expression of PD-L1 in breast invasive lobular carcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0309170

BibTeX
@article{Shin2024,
  author = {Shin, Eunah and Kim, Hye Min and Koo, Ja Seung},
  title = {Expression of PD-L1 in breast invasive lobular carcinoma},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0309170}
}
Kostenlos starten →